EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The effect of immunologic marker levels on the development of postherpetic neuralgia in diabetes mellitus patients with acute herpes zoster

Numan Demiralp, Sema Tuncer Uzun, Gülçin Büyükbezi̇rci̇, Sevgi Keleş, Şule Arıcan, Resul Yılmaz, Ruhiye Reisli, İsmail Reisli

Journal of Surgery and Medicine · 15.06.2026 · 10 (6) · e8588

DOI: 10.28982/josam.8588 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgery and Medicine, online erschienen am 15.06.2026. Verfasst von Numan Demiralp und 7 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aim: Neuropathic pain is a complex condition with an incompletely understood pathogenesis, and immunologic mechanisms are increasingly recognized as important contributors. This study aimed to evaluate the association between immunologic marker levels and the development of postherpetic neuralgia in patients with acute herpes zoster, with a particular focus on the impact of diabetes mellitus.

Methods

In this prospective observational study, 20 patients with acute herpes zoster and a Douleur Neuropathique 4 score of 4 or higher were enrolled. Patients were categorized into two groups: those with diabetes mellitus (Group I, n = 10) and those without diabetes mellitus (Group II, n = 10). Routine laboratory parameters, including hemogram, C-reactive protein, erythrocyte sedimentation rate, fasting blood glucose, and hemoglobin A1c, were recorded. Immunologic markers, including CD3+, CD4+, CD8+, FOXP3+ regulatory T cells, natural killer cell subsets (regulatory, defective, cytotoxic, CD56 bright, and CD56 dim), and NK CD57, were analyzed at baseline and at month 3.

Results

NK defective subset levels were lower in Group I than in Group II at baseline and at month 3 (P = 0.028 and P = 0.037, respectively). During follow-up, significant reductions in CD3+, CD4+, and CD8+ levels were observed in Group I (P = 0.013, P = 0.017, and P = 0.041, respectively), whereas significant decreases in NK defective and NK regulatory subsets were identified in Group II (P = 0.037 and P = 0.047, respectively). At the 3-month assessment, all patients met the study definition of postherpetic neuralgia.

Conclusion

Diabetes mellitus was associated with alterations in natural killer cell subpopulations, suggesting impaired innate immune function in patients with acute herpes zoster. However, within the limitations of this small cohort, diabetes mellitus did not appear to independently increase the risk of postherpetic neuralgia. Larger, well-designed studies are needed to clarify the predictive role of immunologic markers in chronic neuropathic pain outcomes.

Zitieren

APA

Demiralp, N., Uzun, S. T., Büyükbezi̇rci̇, G., Keleş, S., Arıcan, Ş., Yılmaz, R., Reisli, R., & Reisli, İ. (2026). The effect of immunologic marker levels on the development of postherpetic neuralgia in diabetes mellitus patients with acute herpes zoster. Journal of Surgery and Medicine, 10(6), e8588. https://doi.org/10.28982/josam.8588

Vancouver

Demiralp N, Uzun ST, Büyükbezi̇rci̇ G, Keleş S, Arıcan Ş, Yılmaz R, et al. The effect of immunologic marker levels on the development of postherpetic neuralgia in diabetes mellitus patients with acute herpes zoster. Journal of Surgery and Medicine. 2026;10(6):e8588. doi:10.28982/josam.8588

BibTeX
@article{Demiralp2026,
  author = {Demiralp, Numan and Uzun, Sema Tuncer and Büyükbezi̇rci̇, Gülçin and Keleş, Sevgi and Arıcan, Şule and Yılmaz, Resul and Reisli, Ruhiye and Reisli, İsmail},
  title = {The effect of immunologic marker levels on the development of postherpetic neuralgia in diabetes mellitus patients with acute herpes zoster},
  journal = {Journal of Surgery and Medicine},
  year = {2026},
  volume = {10},
  number = {6},
  pages = {e8588},
  doi = {10.28982/josam.8588}
}
Kostenlos starten →